Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy-Reference-Cited by-同舟云学术

Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy

Published:2023-04 Issue:4 Volume:29 Page:277.e1-277.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Lee Dasom,Jordan Aryanna I,Menges Meghan A.,Lazaryan Alexandr,Nishihori Taiga,Gaballa Sameh R.^ORCID,Shah Bijal D,Pinilla-Ibarz Javier,Baluch Aliyah^ORCID,Klinkova Olga V.,Chavez Julio C.,Jain Michael D.^ORCID,Locke Frederick L.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference37 articles.

1. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial;Locke;Lancet Oncol,2019

2. KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma;Wang;N Engl J Med,2020

3. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N Engl J Med,2018

4. Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib;Turtle;J Clin Oncol,2017

5. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma;Logue;Haematologica,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent invasive pneumococcal disease (RIPD) in an immunocompromised patient;Enfermedades Infecciosas y Microbiología Clínica;2024-07

2. Current understanding and management of CAR T cell-associated toxicities;Nature Reviews Clinical Oncology;2024-05-20

3. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

4. Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy;Transplantation and Cellular Therapy;2024-04

5. INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities;Transplantation and Cellular Therapy;2024-01